オルガノイド・サービスの世界市場

オルガノイド・サービスの世界市場は2030年までに112億米ドルに達する見込み

2024年に36億米ドルと推定されるオルガノイド・サービスの世界市場は、2024～2030年の分析期間にCAGR 20.9%で成長し、2030年には112億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである腸は、CAGR 22.9％を記録し、分析期間終了時には35億米ドルに達すると予測されます。肝臓セグメントの成長率は、分析期間でCAGR 21.8％と推定されます。

米国市場は9億7,940万米ドルと推定、中国はCAGR 28.3％で成長予測

米国のオルガノイド・サービス市場は、2024年に9億7,940万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに27億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは28.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.5%と18.8%と予測されています。欧州では、ドイツがCAGR約17.6%で成長すると予測されています。

世界のオルガノイド・サービス市場- 主要動向と促進要因まとめ

なぜオルガノイドは生物医学研究と薬物検査の中心的存在になりつつあるのか？

オルガノイドサービスは、実際の臓器の主要な構造的・機能的側面を再現した、ヒト幹細胞由来の小型化された3次元生物学的モデルの開発、培養、分析を含みます。これらのサービスは、従来の2次元細胞培養や動物モデルよりも生理学的に適切なシステムを提供することで、創薬、疾患モデリング、精密医療に変革をもたらしつつあります。

オルガノイドは、組織特異的な構造、細胞の多様性、遺伝子発現パターンを模倣しているため、がん、神経変性疾患、感染症、希少遺伝性疾患のモデリングに有用です。患者特有の変異を保持するその能力は、薬物の有効性と毒性を患者由来のサンプルで試験できる個別化医療への応用をサポートします。これにより、前臨床研究の予測精度が向上し、後期の医薬品開発の失敗が減少します。

技術プラットフォーム、モデルタイプ、カスタマイズ能力はどのように拡大しているか？

サービスプロバイダーは、人工多能性幹細胞（iPSC）、成体幹細胞、または腫瘍生検を用いて構築された、脳、肝臓、腸、膵臓、腎臓、肺などのオルガノイドモデルを含む、幅広い種類のオルガノイドを提供しています。これらのモデルは、疾患タイプ、変異プロファイル、治療ターゲットに基づいて標準化またはカスタマイズすることができます。高度なイメージング、マルチオミクス・プロファイリング、機能的アッセイが統合され、薬物反応や組織の動態をモニターすることができます。

自動リキッドハンドリングとAI支援データ解析に対応したハイスループットスクリーニングプラットフォームは、オルガノイドベースの試験のスケーラビリティと再現性を高めています。新たな動向としては、オルガノイドとマイクロ流体チップとの統合（organ-on-a-chipシステム）、免疫細胞との共培養モデル、長期展開プロトコールなどがあります。サービスプロバイダーはまた、遺伝子編集、バイオバンク、臨床研究のための患者特異的オルガノイド作製をサポートしています。

どこでサービスが採用され、どのような主要応用分野があるのか？

オルガノイド・サービスは、製薬会社、学術研究機関、受託研究機関、精密医療新興企業の間で急速に普及しています。腫瘍学は最大の応用分野であり、がん治療の試験、患者の反応予測、コンパニオン診断薬の開発に腫瘍由来のオルガノイドが広く利用されています。消化器疾患や神経疾患の調査も、オルガノイドが効果的に複製する複雑な組織行動のために拡大しています。

北米と欧州が主要市場であり、強力な学術インフラ、バイオテクノロジーへの投資、代替検査法への規制当局の関与に支えられています。アジア太平洋は、政府が支援する幹細胞イニシアティブや、再生医療や薬剤スクリーニングへの投資の増加によって成長を遂げています。共同研究ネットワークやバイオファーマとの提携により、トランスレーショナルリサーチにおけるオルガノイド検査サービスの利用が加速しています。

オルガノイド・サービス市場の成長はいくつかの要因によって牽引されています。

オルガノイド・サービス市場の成長は、生理学的に正確な疾患モデルに対する需要、個別化された薬剤スクリーニング・プラットフォームに対するニーズの高まり、幹細胞や患者由来組織を用いた3D培養技術の進歩などの要因によってもたらされます。ハイスループット解析ツールの拡大とイメージング、ゲノミクス、トランスクリプトミクスとの統合が、複雑な機能検査を支えています。

腫瘍学、神経生物学、感染症研究における調査は、動物モデルの限界と倫理的に準拠した試験の推進によって加速しています。オルガノイドを用いた研究開発への資金提供の増加、動物を用いない試験法に対する規制当局の奨励、サービスプロバイダーと製薬企業との協力関係が、世界の需要をさらに刺激しています。スケーラビリティ、凍結保存、プロトコルの標準化の改善により、研究および臨床の領域でより広範な利用が可能になっています。

セグメント

臓器タイプ（腸、肝臓、胃、膵臓、肺、脳、腎臓）、供給源（多能性幹細胞、臓器特異的成体幹細胞）、アプリケーション（発生生物学的疾患アプリケーション、感染症病理学アプリケーション、再生医療アプリケーション、薬物毒性・有効性試験アプリケーション、創薬・個別化医療アプリケーション）

調査対象企業の例

• ATCC
• Crown Bioscience
• DefiniGEN
• Emulate Inc.
• GenScript Biotech Corporation
• HUB Organoids
• InSphero AG
• Inventia Life Science
• JSR Life Sciences
• Kirkstall Ltd.
• Lifeline Cell Technology
• MIMETAS
• Molecular Devices
• Organovo Holdings, Inc.
• Pionyr Immunotherapeutics
• Prellis Biologics, Inc.
• ReproCELL Inc.
• STEMCELL Technologies Inc.
• TissUse GmbH
• Visikol Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Organoids Services Market to Reach US$11.2 Billion by 2030

The global market for Organoids Services estimated at US$3.6 Billion in the year 2024, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 20.9% over the analysis period 2024-2030. Intestine, one of the segments analyzed in the report, is expected to record a 22.9% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Liver segment is estimated at 21.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$979.4 Million While China is Forecast to Grow at 28.3% CAGR

The Organoids Services market in the U.S. is estimated at US$979.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 28.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 18.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.6% CAGR.

Global Organoids Services Market - Key Trends & Drivers Summarized

Why Are Organoids Becoming Central to Biomedical Research and Drug Testing?

Organoid services involve the development, culture, and analysis of miniaturized, three-dimensional biological models derived from human stem cells that replicate key structural and functional aspects of real organs. These services are transforming drug discovery, disease modeling, and precision medicine by offering more physiologically relevant systems than conventional 2D cell cultures or animal models.

Organoids mimic tissue-specific architecture, cellular diversity, and genetic expression patterns, making them valuable for modeling cancer, neurodegenerative conditions, infectious diseases, and rare genetic disorders. Their ability to retain patient-specific mutations supports personalized medicine applications, where drug efficacy and toxicity can be tested on patient-derived samples. This enhances the predictive accuracy of preclinical research and reduces late-stage drug development failures.

How Are Technology Platforms, Model Types, and Customization Capabilities Expanding?

Service providers are offering a broad range of organoid types, including brain, liver, intestinal, pancreatic, kidney, and lung models, built using induced pluripotent stem cells (iPSCs), adult stem cells, or tumor biopsies. These models can be standardized or customized based on disease type, mutation profile, or therapeutic target. Advanced imaging, multi-omics profiling, and functional assays are integrated to monitor drug responses and tissue dynamics.

High-throughput screening platforms compatible with automated liquid handling and AI-assisted data analytics are enhancing the scalability and reproducibility of organoid-based testing. Emerging trends include integration of organoids with microfluidic chips (organ-on-a-chip systems), co-culture models with immune cells, and long-term expansion protocols. Service providers are also supporting gene editing, biobanking, and patient-specific organoid generation for clinical research.

Where Are Services Gaining Adoption and What Are the Primary Application Areas?

Organoid services are seeing rapid uptake among pharmaceutical companies, academic research institutions, contract research organizations, and precision medicine startups. Oncology is the largest application area, with widespread use of tumor-derived organoids for testing cancer therapies, predicting patient response, and developing companion diagnostics. Gastrointestinal and neurological disease research is also expanding due to the complex tissue behaviors that organoids replicate effectively.

North America and Europe are leading markets, supported by strong academic infrastructure, biotech investment, and regulatory engagement in alternative testing methods. Asia-Pacific is experiencing growth through government-backed stem cell initiatives and increasing investment in regenerative medicine and drug screening. Collaborative research networks and biopharma alliances are accelerating the availability of organoid testing services in translational research.

Growth in the Organoids Services market is driven by several factors…

Growth in the organoids services market is driven by factors such as demand for physiologically accurate disease models, rising need for personalized drug screening platforms, and advances in 3D culture techniques using stem cells and patient-derived tissues. Expansion of high-throughput analysis tools and integration with imaging, genomics, and transcriptomics is supporting complex functional testing.

Adoption in oncology, neurobiology, and infectious disease research is being accelerated by the limitations of animal models and the push for ethically compliant testing. Increased funding for organoid-based R&D, regulatory encouragement for non-animal testing methods, and collaborations between service providers and pharmaceutical companies are further stimulating global demand. Improvements in scalability, cryopreservation, and protocol standardization are enabling broader accessibility across research and clinical domains.

SCOPE OF STUDY:

The report analyzes the Organoids Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney); Source (Pluripotent Stem Cells, Organ Specific Adult Stem Cell); Application (Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application, Drug Discovery & Personalized Medicine Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• ATCC
• Crown Bioscience
• DefiniGEN
• Emulate Inc.
• GenScript Biotech Corporation
• HUB Organoids
• InSphero AG
• Inventia Life Science
• JSR Life Sciences
• Kirkstall Ltd.
• Lifeline Cell Technology
• MIMETAS
• Molecular Devices
• Organovo Holdings, Inc.
• Pionyr Immunotherapeutics
• Prellis Biologics, Inc.
• ReproCELL Inc.
• STEMCELL Technologies Inc.
• TissUse GmbH
• Visikol Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Organoids Services - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Physiologically Relevant In Vitro Models Spurs Growth in Organoid-Based Research Services
  • Advancements in 3D Cell Culture and Tissue Engineering Strengthen Business Case for Organoid Platforms
  • Expansion of Precision Medicine and Drug Screening Applications Throws the Spotlight on Patient-Derived Organoids
  • Increasing Limitations of Traditional Animal Models Propel Adoption of Human-Like Organoid Systems
  • Growth in Oncology Research and Personalized Therapeutics Enhances Use of Tumor Organoid Services
  • Rising Investment in Biopharma R&D and Preclinical Testing Supports Outsourcing to Organoid Service Providers
  • Use of Organoids in Infectious Disease Modeling and Vaccine Development Expands Research Applications
  • AI Integration in Organoid Imaging and Data Analysis Strengthens High-Throughput Screening Capabilities
  • Technological Integration with CRISPR and Genomic Editing Tools Enhances Functional Organoid Research
  • Growing Demand for Toxicology and Drug Metabolism Studies Drives Use of Liver and Kidney Organoids
  • Development of Organ-on-a-Chip Hybrids Broadens Scope for Multi-Organ Testing Models
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Organoids Services Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Organoids Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Stomach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Pancreas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Brain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Brain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Brain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Developmental Biology Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Developmental Biology Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Developmental Biology Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Pathology of Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Pathology of Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Pathology of Infectious Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Regenerative Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Regenerative Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Regenerative Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Drug Toxicity & Efficacy Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Drug Toxicity & Efficacy Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Drug Toxicity & Efficacy Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Drug Discovery & Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Drug Discovery & Personalized Medicine Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Drug Discovery & Personalized Medicine Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Pluripotent Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Pluripotent Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Pluripotent Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Organ Specific Adult Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Organ Specific Adult Stem Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Organ Specific Adult Stem Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• JAPAN
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• CHINA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• EUROPE
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Organoids Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• FRANCE
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: France 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: France 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• GERMANY
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Germany 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Germany 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Italy 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Italy 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: UK 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: UK 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Spain 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Spain 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Russia 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Russia 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Organoids Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Australia 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Australia 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• INDIA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: India 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: India 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: South Korea 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: South Korea 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Organoids Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Latin America 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Latin America 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Argentina 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Argentina 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Brazil 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Brazil 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Mexico 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Mexico 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Organoids Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Organoids Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Organoids Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Middle East 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Middle East 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Iran 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Iran 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Israel 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Israel 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: UAE 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: UAE 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030
• AFRICA
  • Organoids Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Organoids Services by Organ Type - Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Organoids Services by Organ Type - Percentage Breakdown of Value Sales for Intestine, Liver, Stomach, Pancreas, Lung, Brain and Kidney for the Years 2014, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Organoids Services by Application - Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Africa 16-Year Perspective for Organoids Services by Application - Percentage Breakdown of Value Sales for Developmental Biology Disease Application, Pathology of Infectious Disease Application, Regenerative Medicine Application, Drug Toxicity & Efficacy Testing Application and Drug Discovery & Personalized Medicine Application for the Years 2014, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Organoids Services by Source - Pluripotent Stem Cells and Organ Specific Adult Stem Cell Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Africa 16-Year Perspective for Organoids Services by Source - Percentage Breakdown of Value Sales for Pluripotent Stem Cells and Organ Specific Adult Stem Cell for the Years 2014, 2025 & 2030

IV. COMPETITION